Trials / Completed
CompletedNCT02138461
Tolerability of Bimatoprost 0.01% vs Latanoprost Eye Drops
Subjective Patient Assessment Comparing Overall Tolerability and Satisfaction of a Prostaglandin Analogue Including Either Bimatoprost 0.01% or Latanoprost.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 211 (actual)
- Sponsor
- MDbackline, LLC · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study examines patient perceptions regarding the tolerability of two classes of glaucoma medication: bimatoprost and latanoprost.
Detailed description
Patients enrolled in this study completed a validated survey instrument (COMTOL) examining tolerability of topically applied ophthalmic medications that they are already taking in their regular course of care for glaucoma. The purpose of the study is to determine whether side effects and symptoms of the drugs already being taken cause problems with activities of daily living.
Conditions
Timeline
- Start date
- 2013-10-01
- Primary completion
- 2014-09-01
- Completion
- 2014-09-01
- First posted
- 2014-05-14
- Last updated
- 2014-09-25
- Results posted
- 2014-09-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02138461. Inclusion in this directory is not an endorsement.